These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38212807)

  • 1. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
    Cooper E; Oyagawa CRM; Johnson R; Choi PJ; Foliaki JM; Correia J; Schweder P; Heppner P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Jose J; Park TI
    Cell Commun Signal; 2024 Jan; 22(1):30. PubMed ID: 38212807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.
    Cooper E; Choi PJ; Hwang K; Nam KM; Kim CY; Shaban T; Schweder P; Mee E; Correia J; Turner C; Faull RLM; Denny WA; Noguchi K; Dragunow M; Jose J; Park TI
    Chem Biol Drug Des; 2023 Mar; 101(3):696-716. PubMed ID: 36323652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
    Cooper E; Choi PJ; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; I-H Park T; Jose J
    Bioorg Med Chem Lett; 2021 Oct; 50():128336. PubMed ID: 34438012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2617-2621. PubMed ID: 31378572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model.
    Parrish KE; Pokorny J; Mittapalli RK; Bakken K; Sarkaria JN; Elmquist WF
    J Pharmacol Exp Ther; 2015 Nov; 355(2):264-71. PubMed ID: 26354993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.
    Choi PJ; Tomek P; Tercel M; Reynisson J; Park TIH; Cooper EA; Denny WA; Jose J; Leung E
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
    Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
    Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
    Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
    Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.
    Usama SM; Jiang Z; Pflug K; Sitcheran R; Burgess K
    ChemMedChem; 2019 Sep; 14(17):1575-1579. PubMed ID: 31322832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1.
    Sheikh MS; Antinore MJ; Huang Y; Fornace AJ
    Oncogene; 1998 Nov; 17(20):2555-63. PubMed ID: 9840918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.
    Mahata B; Biswas S; Rayman P; Chahlavi A; Ko J; Bhattacharjee A; Li YT; Li Y; Das T; Sa G; Raychaudhuri B; Vogelbaum MA; Tannenbaum C; Finke JH; Biswas K
    PLoS One; 2015; 10(7):e0134425. PubMed ID: 26226135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
    Sharma V; Tewari R; Sk UH; Joseph C; Sen E
    Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.
    Tsuruya K; Ninomiya T; Tokumoto M; Hirakawa M; Masutani K; Taniguchi M; Fukuda K; Kanai H; Kishihara K; Hirakata H; Iida M
    Kidney Int; 2003 Jan; 63(1):72-82. PubMed ID: 12472770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer.
    Harada M; Morikawa M; Ozawa T; Kobayashi M; Tamura Y; Takahashi K; Tanabe M; Tada K; Seto Y; Miyazono K; Koinuma D
    Cancer Sci; 2019 Jan; 110(1):209-220. PubMed ID: 30343527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
    Taylor JW; Parikh M; Phillips JJ; James CD; Molinaro AM; Butowski NA; Clarke JL; Oberheim-Bush NA; Chang SM; Berger MS; Prados M
    J Neurooncol; 2018 Nov; 140(2):477-483. PubMed ID: 30151703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.